The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy
- PMID: 11748976
- DOI: 10.1006/gyno.2001.6469
The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy
Abstract
Objectives: The aim of this study was to assess the technique of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy, in relation to perioperative complication rates, and its impact on survival following the procedure.
Methods: A retrospective review was performed of the case notes of 129 consecutive procedures performed between 1989 and 2000 in a regional cancer center. RESULTS. Overall, 48.8% of patients suffered a major or minor complication. Complications relating to bowel anastomosis occurred in 2.4%. Perioperative mortality was 3.1%. Median survival for the group as a whole was 30.6 months. Patients who were optimally debulked had a significantly longer median survival time.
Conclusion: En bloc resection of ovarian cancer with concomitant rectosigmoid colectomy allows a high rate of optimal debulking with acceptable morbidity, mortality, and survival.
Similar articles
-
The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns.Gynecol Oncol. 2006 Dec;103(3):977-84. doi: 10.1016/j.ygyno.2006.06.004. Epub 2006 Jul 11. Gynecol Oncol. 2006. PMID: 16837030
-
Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.Gynecol Oncol. 2009 Aug;114(2):173-7. doi: 10.1016/j.ygyno.2009.05.004. Epub 2009 May 31. Gynecol Oncol. 2009. PMID: 19482344
-
Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.Gynecol Oncol. 2008 Jun;109(3):364-9. doi: 10.1016/j.ygyno.2008.02.020. Epub 2008 Apr 8. Gynecol Oncol. 2008. PMID: 18396322
-
Colon resection for ovarian cancer: intraoperative decisions.Gynecol Oncol. 2008 Nov;111(2 Suppl):S56-65. doi: 10.1016/j.ygyno.2008.07.055. Epub 2008 Oct 2. Gynecol Oncol. 2008. PMID: 18835022 Review.
-
Splenectomy as part of cytoreductive surgery in ovarian cancer.Gynecol Oncol. 2006 Aug;102(2):369-74. doi: 10.1016/j.ygyno.2006.03.028. Epub 2006 Apr 24. Gynecol Oncol. 2006. PMID: 16631919 Review.
Cited by
-
The value of transitory protective stomas during primary debulking surgery for advanced epithelial ovarian cancer: a retrospective cohort study.Int J Surg. 2024 Nov 1;110(11):6922-6932. doi: 10.1097/JS9.0000000000001474. Int J Surg. 2024. PMID: 38626439 Free PMC article.
-
Rectosigmoid sparing en bloc pelvic resection for fixed ovarian tumors: Surgical technique and perioperative and oncologic outcomes.Front Oncol. 2022 Aug 22;12:980050. doi: 10.3389/fonc.2022.980050. eCollection 2022. Front Oncol. 2022. PMID: 36072802 Free PMC article.
-
Mesenteric Lymph Node Involvement as a Prognostic Factor in Ovarian Cancer: A Study Using a Standardized Detection Method.Ann Surg Oncol. 2025 Jul 12. doi: 10.1245/s10434-025-17779-8. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40652147
-
Total pelvic exenteration for pelvic recurrence after advanced epithelial ovarian cancer--A case report and literature review.J Med Life. 2015 Jul-Sep;8(3):263-5. J Med Life. 2015. PMID: 26351524 Free PMC article. Review.
-
En bloc pelvic resection of ovarian cancer with rectosigmoid colectomy: a literature review.Gland Surg. 2021 Mar;10(3):1195-1206. doi: 10.21037/gs-19-540. Gland Surg. 2021. PMID: 33842265 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials